Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 130/0.42 + balanced electrolytes vs 5% albumin + saline in compensated renal failure
2006-001879-38Phase 4Terminated
- Sponsor
- B. Braun
- Start
- Dec 2008
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial in chronic kidney disease (CKD) and acid-base disorder comparing HES 130/0.42 + balanced electrolytes with Albumin 5% + NaCl 0.9% (2 arms). Primary endpoint: base excess. Started Dec 2008; status: terminated.
02
Drugs
hydroxyethyl starch 130/0.42albumin (human)
03
Conditions
chronic kidney disease (CKD)acid-base disorder
Beyond the preview
Go deeper on 2006-001879-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001879-38.